{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:36:35Z","timestamp":1791488195303,"version":"4.3.4"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1475-2875-12-418","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T04:01:12Z","timestamp":1384488072000},"source":"Crossref","is-referenced-by-count":135,"title":["Spatial distribution of G6PD deficiency variants across malaria-endemic regions"],"prefix":"10.1186","volume":"12","author":[{"given":"Rosalind E","family":"Howes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mewahyu","family":"Dewi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric B","family":"Piel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuelton M","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E","family":"Battle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane P","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anavaj","family":"Sakuntabhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari W","family":"Satyagraha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas N","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Kevin","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon I","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,15]]},"reference":[{"key":"3020_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1126\/science.124.3220.484-a","volume":"124","author":"PE Carson","year":"1956","unstructured":"Carson PE, Flanagan CL, Ickes CE, Alving AS: Enzymatic deficiency in primaquine-sensitive erythrocytes. Science. 1956, 124: 484-485.","journal-title":"Science"},{"key":"3020_CR2","doi-asserted-by":"publisher","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI: G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012, 9: e1001339-10.1371\/journal.pmed.1001339.","journal-title":"PLoS Med"},{"key":"3020_CR3","doi-asserted-by":"publisher","first-page":"e1000396","DOI":"10.1371\/journal.pmed.1000396","volume":"8","author":"The malERA Consultative Group on Diagnoses and Diagnostics","year":"2011","unstructured":"The malERA Consultative Group on Diagnoses and Diagnostics: A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med. 2011, 8: e1000396-","journal-title":"PLoS Med"},{"key":"3020_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pt.2010.08.005","volume":"27","author":"JK Baird","year":"2011","unstructured":"Baird JK, Surjadjaja C: Consideration of ethics in primaquine therapy against malaria transmission. Trends Parasitol. 2011, 27: 11-16. 10.1016\/j.pt.2010.08.005.","journal-title":"Trends Parasitol"},{"key":"3020_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/CMR.00074-12","volume":"26","author":"JK Baird","year":"2013","unstructured":"Baird JK: Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013, 26: 36-57. 10.1128\/CMR.00074-12.","journal-title":"Clin Microbiol Rev"},{"key":"3020_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1517\/14728214.2012.720252","volume":"17","author":"JK Baird","year":"2012","unstructured":"Baird JK: Reinventing primaquine for endemic malaria. Expet Opin Emerg Drugs. 2012, 17: 439-444. 10.1517\/14728214.2012.720252.","journal-title":"Expet Opin Emerg Drugs"},{"issue":"Suppl 1","key":"3020_CR7","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1186\/1475-2875-7-S1-S8","volume":"7","author":"NJ White","year":"2008","unstructured":"White NJ: The role of anti-malarial drugs in eliminating malaria. Malar J. 2008, 7 (Suppl 1): S8-10.1186\/1475-2875-7-S1-S8.","journal-title":"Malar J"},{"key":"3020_CR8","doi-asserted-by":"publisher","first-page":"e1000402","DOI":"10.1371\/journal.pmed.1000402","volume":"8","author":"The malERA Consultative Group on Drugs","year":"2011","unstructured":"The malERA Consultative Group on Drugs: A research agenda for malaria eradication: drugs. PLoS Med. 2011, 8: e1000402-","journal-title":"PLoS Med"},{"key":"3020_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ: Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011, 10: 297-10.1186\/1475-2875-10-297.","journal-title":"Malar J"},{"key":"3020_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/CMR.00051-10","volume":"24","author":"T Bousema","year":"2011","unstructured":"Bousema T, Drakeley C: Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011, 24: 377-410. 10.1128\/CMR.00051-10.","journal-title":"Clin Microbiol Rev"},{"key":"3020_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","volume":"13","author":"NJ White","year":"2012","unstructured":"White NJ: Primaquine to prevent transmission of falciparum malaria. Lancet Infect Dis. 2012, 13: 175-181.","journal-title":"Lancet Infect Dis"},{"key":"3020_CR12","volume-title":"Guidelines for the treatment of malaria, second edition","author":"WHO","year":"2010","unstructured":"WHO: Guidelines for the treatment of malaria, second edition. 2010, Geneva: World Health Organization"},{"key":"3020_CR13","volume-title":"Global plan for artemisinin resistance containment (GPARC)","author":"WHO","year":"2011","unstructured":"WHO: Global plan for artemisinin resistance containment (GPARC). 2011, Geneva: WHO"},{"key":"3020_CR14","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-11-418","volume":"11","author":"NJ White","year":"2012","unstructured":"White NJ, Qiao LG, Qi G, Luzzatto L: Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common. Malar J. 2012, 11: 418-10.1186\/1475-2875-11-418.","journal-title":"Malar J"},{"key":"3020_CR15","doi-asserted-by":"publisher","first-page":"e37166","DOI":"10.1371\/journal.pone.0037166","volume":"7","author":"RJ Maude","year":"2012","unstructured":"Maude RJ, Socheat D, Nguon C, Saroth P, Dara P, Li G, Song J, Yeung S, Dondorp AM, Day NP, White NJ, White LJ: Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. PLoS One. 2012, 7: e37166-10.1371\/journal.pone.0037166.","journal-title":"PLoS One"},{"key":"3020_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/ajpa.1330360609","volume":"36","author":"LS Greene","year":"1993","unstructured":"Greene LS: G6PD deficiency as protection against falciparum-malaria: an epidemiologic critique of population and experimental studies. Yearb Phys Anthropol. 1993, 36: 153-178. 10.1002\/ajpa.1330360609.","journal-title":"Yearb Phys Anthropol"},{"key":"3020_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1086\/432519","volume":"77","author":"DP Kwiatkowski","year":"2005","unstructured":"Kwiatkowski DP: How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet. 2005, 77: 171-192. 10.1086\/432519.","journal-title":"Am J Hum Genet"},{"key":"3020_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0268-960X(96)90019-3","volume":"10","author":"E Beutler","year":"1996","unstructured":"Beutler E: G6PD: population genetics and clinical manifestations. Blood Rev. 1996, 10: 45-52. 10.1016\/S0268-960X(96)90019-3.","journal-title":"Blood Rev"},{"key":"3020_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1473-3099(09)70177-X","volume":"9","author":"I Mueller","year":"2009","unstructured":"Mueller I, Galinski MR, Baird JK, Carlton JM, Kochar DK, Alonso PL, del Portillo HA: Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009, 9: 555-566. 10.1016\/S1473-3099(09)70177-X.","journal-title":"Lancet Infect Dis"},{"key":"3020_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(08)60073-2","volume":"371","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Fiorelli G: Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008, 371: 64-74. 10.1016\/S0140-6736(08)60073-2.","journal-title":"Lancet"},{"key":"3020_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/B978-0-12-407826-0.00004-7","volume":"81","author":"RE Howes","year":"2013","unstructured":"Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI: G6PD deficiency: Global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013, 81: 133-201.","journal-title":"Adv Parasitol"},{"key":"3020_CR22","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","volume":"380","author":"CJ Murray","year":"2012","unstructured":"Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basanez MG, Baxter A, Bell ML, Benjamin EJ: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012, 380: 2197-2223. 10.1016\/S0140-6736(12)61689-4.","journal-title":"Lancet"},{"key":"3020_CR23","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012, 380: 2095-2128. 10.1016\/S0140-6736(12)61728-0.","journal-title":"Lancet"},{"key":"3020_CR24","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/cid\/cis615","volume":"55","author":"MV Lacerda","year":"2012","unstructured":"Lacerda MV, Fragoso SC, Alecrim MG, Alexandre MA, Magalhaes BM, Siqueira AM, Ferreira LC, Araujo JR, Mourao MP, Ferrer M, Castillo P, Martin-Jaular L, Fernandez-Becerra C, del Portillo H, Ordi J, Alonso PL, Bassat Q: Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill?. Clin Infect Dis. 2012, 55: e67-e74. 10.1093\/cid\/cis615.","journal-title":"Clin Infect Dis"},{"key":"3020_CR25","volume-title":"Nathan and Oski\u2019s Hematology of Infancy and Childhood","author":"L Luzzatto","year":"2009","unstructured":"Luzzatto L: Glucose-6-phosphate dehydrogenase deficiency. Nathan and Oski\u2019s Hematology of Infancy and Childhood. Edited by: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, Lux SE. 2009, Philadelphia: Saunders, 7","edition":"7"},{"key":"3020_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bcmd.2012.01.001","volume":"48","author":"A Minucci","year":"2012","unstructured":"Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E: Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the \"old\" and update of the new mutations. Blood Cells Mol Dis. 2012, 48: 154-165. 10.1016\/j.bcmd.2012.01.001.","journal-title":"Blood Cells Mol Dis"},{"key":"3020_CR27","volume-title":"Encyclopedia of Life Sciences","author":"PJ Mason","year":"2005","unstructured":"Mason PJ, Vulliamy TJ: Glucose-6-phosphate dehydrogenase (G6PD) deficiency: genetics. Encyclopedia of Life Sciences. 2005, Chichester: John Wiley & Sons, Ltd"},{"key":"3020_CR28","first-page":"601","volume":"67","author":"WHO Working Group","year":"1989","unstructured":"WHO Working Group: Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989, 67: 601-611.","journal-title":"Bull World Health Organ"},{"key":"3020_CR29","first-page":"243","volume":"45","author":"A Yoshida","year":"1971","unstructured":"Yoshida A, Beutler E, Motulsky AG: Human glucose-6-phosphate dehydrogenase variants. Bull World Health Organ. 1971, 45: 243-253.","journal-title":"Bull World Health Organ"},{"key":"3020_CR30","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.1952.72930340027010c","volume":"149","author":"RS Hockwald","year":"1952","unstructured":"Hockwald RS, Arnold J, Clayman CB, Alving AS: Toxicity of primaquine in Negroes. JAMA. 1952, 149: 1568-1570. 10.1001\/jama.1952.72930340027010c.","journal-title":"JAMA"},{"key":"3020_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJM199101173240306","volume":"324","author":"E Beutler","year":"1991","unstructured":"Beutler E: Glucose-6-phosphate dehydrogenase deficiency. N Engl J Med. 1991, 324: 169-174. 10.1056\/NEJM199101173240306.","journal-title":"N Engl J Med"},{"key":"3020_CR32","first-page":"171","volume":"44","author":"RJ Dern","year":"1954","unstructured":"Dern RJ, Beutler E, Alving AS: The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med. 1954, 44: 171-176.","journal-title":"J Lab Clin Med"},{"key":"3020_CR33","first-page":"621","volume":"22","author":"AS Alving","year":"1960","unstructured":"Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE: Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ. 1960, 22: 621-631.","journal-title":"Bull World Health Organ"},{"key":"3020_CR34","volume-title":"The History and Geography of Human Genes","author":"LL Cavalli-Sforza","year":"1994","unstructured":"Cavalli-Sforza LL, Menozzi P, Piazza A: The History and Geography of Human Genes. 1994, Princeton, New Jersey: Princeton University Press"},{"key":"3020_CR35","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1172\/JCI105786","volume":"47","author":"S Piomelli","year":"1968","unstructured":"Piomelli S, Corash LM, Davenport DD, Miraglia J, Amorosi EL: In vivo lability of glucose-6-phosphate dehydrogenase in GdA- and GdMediterranean deficiency. J Clin Invest. 1968, 47: 940-948. 10.1172\/JCI105786.","journal-title":"J Clin Invest"},{"key":"3020_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000206700","volume":"70","author":"T Meloni","year":"1983","unstructured":"Meloni T, Forteleoni G, Dore A, Cutillo S: Favism and hemolytic anemia in glucose-6-phosphate dehydrogenase-deficient subjects in North Sardinia. Acta Haematol. 1983, 70: 83-90. 10.1159\/000206700.","journal-title":"Acta Haematol"},{"key":"3020_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/jama.1940.02810340060025","volume":"115","author":"A Luisada","year":"1940","unstructured":"Luisada A: Favism. JAMA. 1940, 115: 632-632.","journal-title":"Favism. JAMA"},{"key":"3020_CR38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4269\/ajtmh.2007.77.779","volume":"77","author":"E Beutler","year":"2007","unstructured":"Beutler E, Duparc S: Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg. 2007, 77: 779-789.","journal-title":"Am J Trop Med Hyg"},{"key":"3020_CR39","first-page":"391","volume":"59","author":"DF Clyde","year":"1981","unstructured":"Clyde DF: Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug. Bull World Health Organ. 1981, 59: 391-395.","journal-title":"Bull World Health Organ"},{"key":"3020_CR40","first-page":"720","volume":"32","author":"K Buchachart","year":"2001","unstructured":"Buchachart K, Krudsood S, Singhasivanon P, Treeprasertsuk S, Phophak N, Srivilairit S, Chalermrut K, Rattanapong Y, Supeeranuntha L, Wilairatana P, Brittenham G, Looareesuwan S: Effect of primaquine standard dose (15 mg\/day for 14 days) in the treatment of vivax malaria patients in Thailand. Southeast Asian J Trop Med Public Health. 2001, 32: 720-726.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"3020_CR41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s10038-004-0187-7","volume":"49","author":"H Matsuoka","year":"2004","unstructured":"Matsuoka H, Wang J, Hirai M, Arai M, Yoshida S, Kobayashi T, Jalloh A, Lin K, Kawamoto F: Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G\u2009>\u2009A) is the most common variant in the Myanmar population. J Hum Genet. 2004, 49: 544-547. 10.1007\/s10038-004-0187-7.","journal-title":"J Hum Genet"},{"key":"3020_CR42","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1178849","volume":"326","author":"C Louicharoen","year":"2009","unstructured":"Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Peerapittayamongkol C, Casademont I, Sura T, Laird NM, Singhasivanon P, Quintana-Murci L, Sakuntabhai A: Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science. 2009, 326: 1546-1549. 10.1126\/science.1178849.","journal-title":"Science"},{"key":"3020_CR43","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/1475-2875-9-376","volume":"9","author":"KL Burgoine","year":"2010","unstructured":"Burgoine KL, Bancone G, Nosten F: The reality of using primaquine. Malar J. 2010, 9: 376-10.1186\/1475-2875-9-376.","journal-title":"Malar J"},{"key":"3020_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1532\/IJH97.A20513","volume":"83","author":"V Laosombat","year":"2006","unstructured":"Laosombat V, Sattayasevana B, Chotsampancharoen T, Wongchanchailert M: Glucose-6-phosphate dehydrogenase variants associated with favism in Thai children. Int J Hematol. 2006, 83: 139-143. 10.1532\/IJH97.A20513.","journal-title":"Int J Hematol"},{"key":"3020_CR45","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s11908-012-0250-z","volume":"14","author":"JK Baird","year":"2012","unstructured":"Baird JK: Elimination therapy for the endemic malarias. Curr Infect Dis Rep. 2012, 14: 227-237. 10.1007\/s11908-012-0250-z.","journal-title":"Curr Infect Dis Rep"},{"key":"3020_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.blre.2007.05.002","volume":"21","author":"PJ Mason","year":"2007","unstructured":"Mason PJ, Bautista JM, Gilsanz F: G6PD deficiency: the genotype-phenotype association. Blood Rev. 2007, 21: 267-283. 10.1016\/j.blre.2007.05.002.","journal-title":"Blood Rev"},{"key":"3020_CR47","volume-title":"The distribution of the human blood groups and other polymorphisms","author":"AE Mourant","year":"1976","unstructured":"Mourant AE, Kopec AC, Domaniewska-Sobczak K: The distribution of the human blood groups and other polymorphisms. 1976, London: Oxford University Press"},{"key":"3020_CR48","volume-title":"Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants and ovalocytosis in human populations","author":"FB Livingstone","year":"1985","unstructured":"Livingstone FB: Frequencies of hemoglobin variants: thalassemia, the glucose-6-phosphate dehydrogenase deficiency, G6PD variants and ovalocytosis in human populations. 1985, New York: Oxford University Press"},{"key":"3020_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","volume":"42","author":"ET Nkhoma","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E: The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009, 42: 267-278. 10.1016\/j.bcmd.2008.12.005.","journal-title":"Blood Cells Mol Dis"},{"key":"3020_CR50","first-page":"1225","volume":"9","author":"S Singh","year":"1973","unstructured":"Singh S: Distribution of certain polymorphic traits in populations of the Indian peninsula and South Asia. Isr J Med Sci. 1973, 9: 1225-1237.","journal-title":"Isr J Med Sci"},{"key":"3020_CR51","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1186\/1475-2875-10-378","volume":"10","author":"PW Gething","year":"2011","unstructured":"Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IR, Johnston GL, Tatem AJ, Hay SI: A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J. 2011, 10: 378-10.1186\/1475-2875-10-378.","journal-title":"Malar J"},{"key":"3020_CR52","doi-asserted-by":"publisher","first-page":"e1814","DOI":"10.1371\/journal.pntd.0001814","volume":"6","author":"PW Gething","year":"2012","unstructured":"Gething PW, Elyazar IR, Moyes CL, Smith DL, Battle KE, Guerra CA, Patil AP, Tatem AJ, Howes RE, Myers MF, George DB, Horby P, Wertheim HFL, Price RN, Mueller I, Baird JK, Hay SI: A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis. 2012, 6: e1814-10.1371\/journal.pntd.0001814.","journal-title":"PLoS Negl Trop Dis"},{"key":"3020_CR53","doi-asserted-by":"publisher","first-page":"e1000048","DOI":"10.1371\/annotation\/a7ab5bb8-c3bb-4f01-aa34-65cc53af065d","volume":"6","author":"SI Hay","year":"2009","unstructured":"Hay SI, Guerra CA, Gething PW, Patil AP, Tatem AJ, Noor AM, Kabaria CW, Manh BH, Elyazar IR, Brooker S, Smith DL, Moyeed RA, Snow RW: A world malaria map: Plasmodium falciparum endemicity in 2007. PLoS Med. 2009, 6: e1000048-","journal-title":"PLoS Med"},{"key":"3020_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-397900-1.00001-3","volume":"80","author":"KE Battle","year":"2012","unstructured":"Battle KE, Gething PW, Elyazar IR, Moyes CL, Sinka ME, Howes RE, Guerra CA, Price RN, Baird KJ, Hay SI: The global public health significance of Plasmodium vivax. Adv Parasitol. 2012, 80: 1-111.","journal-title":"Adv Parasitol"},{"key":"3020_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(04)01043-6","volume":"4","author":"SI Hay","year":"2004","unstructured":"Hay SI, Guerra CA, Tatem AJ, Noor AM, Snow RW: The global distribution and population at risk of malaria: past, present, and future. Lancet Infect Dis. 2004, 4: 327-336. 10.1016\/S1473-3099(04)01043-6.","journal-title":"Lancet Infect Dis"},{"key":"3020_CR56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","volume":"64","author":"K Mendis","year":"2001","unstructured":"Mendis K, Sina BJ, Marchesini P, Carter R: The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001, 64: 97-106.","journal-title":"Am J Trop Med Hyg"},{"key":"3020_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jiph.2011.03.002","volume":"4","author":"H Singh","year":"2011","unstructured":"Singh H, Parakh A, Basu S, Rath B: Plasmodium vivax malaria: is it actually benign?. J Infect Pub Health. 2011, 4: 91-95. 10.1016\/j.jiph.2011.03.002.","journal-title":"J Infect Pub Health"},{"key":"3020_CR58","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1756-3305-5-154","volume":"5","author":"H Mahgoub","year":"2012","unstructured":"Mahgoub H, Gasim GI, Musa IR, Adam I: Severe Plasmodium vivax malaria among Sudanese children at New Halfa Hospital, Eastern Sudan. Parasit Vectors. 2012, 5: 154-10.1186\/1756-3305-5-154.","journal-title":"Parasit Vectors"},{"key":"3020_CR59","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1093\/cid\/ciq249","volume":"52","author":"NM Douglas","year":"2011","unstructured":"Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, Singhasivanon P, White NJ, Price RN: Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin Infect Dis. 2011, 52: 612-620. 10.1093\/cid\/ciq249.","journal-title":"Clin Infect Dis"},{"key":"3020_CR60","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/1475-2875-9-254","volume":"9","author":"I Harris","year":"2010","unstructured":"Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, Lilley K, Krause D, Vallely A, Johnson ML, Gatton ML, Shanks GD, Cheng Q: A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J. 2010, 9: 254-10.1186\/1475-2875-9-254.","journal-title":"Malar J"},{"key":"3020_CR61","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/1475-2875-11-360","volume":"11","author":"AC Eziefula","year":"2012","unstructured":"Eziefula AC, Gosling R, Hwang J, Hsiang MS, Bousema T, Von Seidlein L, Drakeley C, On behalf of the Primaquine in Africa Discussion Group: Rationale for short course primaquine in Africa to interrupt malaria transmission. Malar J. 2012, 11: 360-10.1186\/1475-2875-11-360.","journal-title":"Malar J"},{"key":"3020_CR62","volume-title":"WHO Evidence Review Group Report: the safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide","author":"Malaria Policy Advisory Committee Meeting","year":"2012","unstructured":"Malaria Policy Advisory Committee Meeting: WHO Evidence Review Group Report: the safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. 2012, Geneva: World Health Organization"},{"key":"3020_CR63","volume-title":"Updated WHO Policy Recommendation: Single dose Primaquine as a gametocytocide in Plasmodium falciparum malaria","author":"WHO Global Malaria Programme","year":"2012","unstructured":"Global Malaria Programme WHO: Updated WHO Policy Recommendation: Single dose Primaquine as a gametocytocide in Plasmodium falciparum malaria. 2012, Geneva: World Health Organization"},{"key":"3020_CR64","first-page":"285","volume":"9","author":"JH Edgcomb","year":"1950","unstructured":"Edgcomb JH, Arnold J, Yount EH, Alving AS, Eichelberger L, Jeffery GM, Eyles D, Young MD: Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc. 1950, 9: 285-292.","journal-title":"J Natl Malar Soc"},{"key":"3020_CR65","doi-asserted-by":"crossref","first-page":"970","DOI":"10.4269\/ajtmh.1953.2.970","volume":"2","author":"AS Alving","year":"1953","unstructured":"Alving AS, Hankey DD, Coatney GR, Jones R, Coker WG, Garrison PL, Donovan WN: Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg. 1953, 2: 970-976.","journal-title":"Am J Trop Med Hyg"},{"key":"3020_CR66","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4269\/ajtmh.1953.2.985","volume":"2","author":"GR Coatney","year":"1953","unstructured":"Coatney GR, Alving AS, Jones R, Hankey DD, Robinson DH, Garrison PL, Coker WG, Donovan WN, Di Lorenzo A, Marx RL, Simmons IH: Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg. 1953, 2: 985-988.","journal-title":"Am J Trop Med Hyg"},{"key":"3020_CR67","first-page":"600","volume":"51","author":"CL Flanagan","year":"1958","unstructured":"Flanagan CL, Schrier SL, Carson PE, Alving AS: The hemolytic effect of primaquine. VIII. The effect of drug administration on parameters of primaquine sensitivity. J Lab Clin Med. 1958, 51: 600-608.","journal-title":"J Lab Clin Med"},{"key":"3020_CR68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1182\/blood.V14.2.103.103","volume":"14","author":"E Beutler","year":"1959","unstructured":"Beutler E: The hemolytic effect of primaquine and related compounds: a review. Blood. 1959, 14: 103-139.","journal-title":"Blood"},{"key":"3020_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1172\/JCI101956","volume":"27","author":"AS Alving","year":"1948","unstructured":"Alving AS, Craige B, Pullman TN, Whorton CM, Jones R, Eichelberger L: Procedures used at Stateville Penitentiary for the testing of potential antimalarial agents. J Clin Invest. 1948, 27: 2-5. 10.1172\/JCI101956.","journal-title":"J Clin Invest"},{"key":"3020_CR70","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1128\/AAC.01135-09","volume":"54","author":"SA Shekalaghe","year":"2010","unstructured":"Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S, Koenderink JB, Luty AJ, Whitty CJ, Drakeley C, Sauerwein RW, Bousema T: In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals. Antimicrob Agents Chemother. 2010, 54: 1762-1768. 10.1128\/AAC.01135-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"3020_CR71","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0140-6736(10)60396-0","volume":"376","author":"L Luzzatto","year":"2010","unstructured":"Luzzatto L: The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics. Lancet. 2010, 376: 739-741. 10.1016\/S0140-6736(10)60396-0.","journal-title":"Lancet"},{"key":"3020_CR72","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2012-03-416032","volume":"120","author":"A Pamba","year":"2012","unstructured":"Pamba A, Richardson ND, Carter N, Duparc S, Premji Z, Tiono AB, Luzzatto L: Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood. 2012, 120: 4123-4133. 10.1182\/blood-2012-03-416032.","journal-title":"Blood"},{"key":"3020_CR73","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/bmj.300.6719.236","volume":"300","author":"S Galiano","year":"1990","unstructured":"Galiano S, Gaetani GF, Barabino A, Cottafava F, Zeitlin H, Town M, Luzzatto L: Favism in the African type of glucose-6-phosphate dehydrogenase deficiency (A-). BMJ. 1990, 300: 236-","journal-title":"BMJ"},{"key":"3020_CR74","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/pgmj.70.830.871","volume":"70","author":"AB Mehta","year":"1994","unstructured":"Mehta AB: Glucose-6-phosphate dehydrogenase deficiency. Postgrad Med J. 1994, 70: 871-877. 10.1136\/pgmj.70.830.871.","journal-title":"Postgrad Med J"},{"key":"3020_CR75","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/ejhg.2009.8","volume":"17","author":"TG Clark","year":"2009","unstructured":"Clark TG, Fry AE, Auburn S, Campino S, Diakite M, Green A, Richardson A, Teo YY, Small K, Wilson J, Jallow M, Sisay-Joof F, Pinder M, Sabeti P, Kwiatkowski DP, Rockett KA: Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet. 2009, 17: 1080-1085. 10.1038\/ejhg.2009.8.","journal-title":"Eur J Hum Genet"},{"key":"3020_CR76","unstructured":"1000 Genomes - A Deep Catalog of Human Genetic Variation. http:\/\/www.1000genomes.org ,"},{"key":"3020_CR77","unstructured":"International HapMap Project. http:\/\/hapmap.ncbi.nlm.nih.gov ,"},{"key":"3020_CR78","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ncomms1265","volume":"2","author":"RE Howes","year":"2011","unstructured":"Howes RE, Patil AP, Piel FB, Nyangiri OA, Kabaria CW, Gething PW, Zimmerman PA, Barnadas C, Beall CM, Gebremedhin A, Menard D, Williams TN, Weatherall DJ, Hay SI: The global distribution of the Duffy blood group. Nat Commun. 2011, 2: 266-","journal-title":"Nat Commun"},{"key":"3020_CR79","volume-title":"World Malaria Report 2012","author":"WHO","year":"2012","unstructured":"WHO: World Malaria Report 2012. 2012, Geneva: World Health Organization"},{"key":"3020_CR80","volume-title":"An Introduction to Malariology","author":"MF Boyd","year":"1930","unstructured":"Boyd MF: An Introduction to Malariology. 1930, Cambridge, MA: Harvard University Press"},{"key":"3020_CR81","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1371\/journal.pntd.0000774","volume":"4","author":"CA Guerra","year":"2010","unstructured":"Guerra CA, Howes RE, Patil AP, Gething PW, Van Boeckel TP, Temperley WH, Kabaria CW, Tatem AJ, Manh BH, Elyazar IR, Baird JK, Snow RW, Hay SI: The international limits and population at risk of Plasmodium vivax transmission in 2009. PLoS Negl Trop Dis. 2010, 4: e774-10.1371\/journal.pntd.0000774.","journal-title":"PLoS Negl Trop Dis"},{"key":"3020_CR82","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4269\/ajtmh.2006.75.575","volume":"75","author":"JR Ryan","year":"2006","unstructured":"Ryan JR, Stoute JA, Amon J, Dunton RF, Mtalib R, Koros J, Owour B, Luckhart S, Wirtz RA, Barnwell JW, Rosenberg R: Evidence for transmission of Plasmodium vivax among a duffy antigen negative population in Western Kenya. Am J Trop Med Hyg. 2006, 75: 575-581.","journal-title":"Am J Trop Med Hyg"},{"key":"3020_CR83","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1086\/644510","volume":"200","author":"R Culleton","year":"2009","unstructured":"Culleton R, Ndounga M, Zeyrek FY, Coban C, Casimiro PN, Takeo S, Tsuboi T, Yadava A, Carter R, Tanabe K: Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa. J Infect Dis. 2009, 200: 1465-1469. 10.1086\/644510.","journal-title":"J Infect Dis"},{"key":"3020_CR84","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1073\/pnas.0912496107","volume":"107","author":"D Menard","year":"2010","unstructured":"Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau-Puijalon O, Zimmerman PA: Plasmodium vivax clinical malaria is commonly observed in duffy-negative malagasy people. Proc Natl Acad Sci USA. 2010, 107: 5967-5971. 10.1073\/pnas.0912496107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3020_CR85","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1371\/journal.pntd.0001192","volume":"5","author":"C Mendes","year":"2011","unstructured":"Mendes C, Dias F, Figueiredo J, Mora VG, Cano J, De Sousa B, Do Rosario VE, Benito A, Berzosa P, Arez AP: Duffy negative antigen is no longer a barrier to plasmodium vivax--molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Negl Trop Dis. 2011, 5: e1192-10.1371\/journal.pntd.0001192.","journal-title":"PLoS Negl Trop Dis"},{"key":"3020_CR86","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/1475-2875-10-336","volume":"10","author":"N Wurtz","year":"2011","unstructured":"Wurtz N, Mint Lekweiry K, Bogreau H, Pradines B, Rogier C, Ould Mohamed Salem Boukhary A, Hafid JE, Ould Ahmedou Salem MS, Trape JF, Basco LK, Briolant S: Vivax malaria in mauritania includes infection of a duffy-negative individual. Malar J. 2011, 10: 336-10.1186\/1475-2875-10-336.","journal-title":"Malar J"},{"key":"3020_CR87","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/S0140-6736(10)61270-6","volume":"376","author":"RG Feachem","year":"2010","unstructured":"Feachem RG, Phillips AA, Hwang J, Cotter C, Wielgosz B, Greenwood BM, Sabot O, Rodriguez MH, Abeyasinghe RR, Ghebreyesus TA, Snow RW: Shrinking the malaria map: progress and prospects. Lancet. 2010, 376: 1566-1578. 10.1016\/S0140-6736(10)61270-6.","journal-title":"Lancet"},{"issue":"9895","key":"3020_CR88","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0140-6736(13)60310-4","volume":"382","author":"C Cotter","year":"2013","unstructured":"Cotter C, Sturrock HJ, Hsiang MS, Liu J, Phillips AA, Hwang J, Gueye CS, Fullman N, Gosling RD, Feachem RG: The changing epidemiology of malaria elimination: new strategies for new challenges. Lancet. 2013, 382 (9895): 900-911. 10.1016\/S0140-6736(13)60310-4.","journal-title":"Lancet"},{"key":"3020_CR89","volume-title":"Atlas of Malaria-Eliminating Countries","author":"UCSF Global Health Group and Malaria Atlas Project","year":"2011","unstructured":"UCSF Global Health Group and Malaria Atlas Project: Atlas of Malaria-Eliminating Countries. 2011, University of California, San Francisco: The Global Health Group, Global Health Sciences"},{"key":"3020_CR90","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1016\/S0140-6736(10)61084-7","volume":"376","author":"SI Hay","year":"2010","unstructured":"Hay SI, Gething PW, Snow RW: India\u2019s invisible malaria burden. Lancet. 2010, 376: 1716-1717. 10.1016\/S0140-6736(10)61084-7.","journal-title":"Lancet"},{"key":"3020_CR91","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nature11174","volume":"487","author":"M Manske","year":"2012","unstructured":"Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, O\u2019Brien J, Djimde A, Doumbo O, Zongo I, Ouedraogo JB, Michon P, Mueller I, Siba P, Nzila A, Borrmann S, Kiara SM, Marsh K, Jiang H, Su XZ, Amaratunga C, Fairhurst R, Socheat D, Nosten F, Imwong M, White NJ, Sanders M, Anastasi E, Alcock D, Drury E: Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature. 2012, 487: 375-379. 10.1038\/nature11174.","journal-title":"Nature"},{"key":"3020_CR92","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1475-2875-9-308","volume":"9","author":"R Takeuchi","year":"2010","unstructured":"Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, Puangsa-art S, Thanyavanich N, Maneeboonyang W, Day NP, Singhasivanon P: Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J. 2010, 9: 308-10.1186\/1475-2875-9-308.","journal-title":"Malar J"},{"key":"3020_CR93","first-page":"710","volume":"25","author":"K Myat Phone","year":"1994","unstructured":"Myat Phone K, Myint O, Aung N, Aye Lwin H: The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar. Southeast Asian J Trop Med Public Health. 1994, 25: 710-713.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"3020_CR94","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1475-2875-9-57","volume":"9","author":"J Song","year":"2010","unstructured":"Song J, Socheat D, Tan B, Dara P, Deng C, Sokunthea S, Seila S, Ou F, Jian H, Li G: Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J. 2010, 9: 57-10.1186\/1475-2875-9-57.","journal-title":"Malar J"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T01:02:11Z","timestamp":1596848531000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-12-418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-12-418","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,15]]},"article-number":"418"}}